Molecular Targeting Technologies, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.mtarget.com
177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors
Phase 1
Recruiting
- Conditions
- Neuroendocrine Tumors
- Interventions
- Other: Amino Acid Solution
- First Posted Date
- 2022-07-26
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Molecular Targeting Technologies, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT05475210
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Study of 99mTc-glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients.
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2013-10-24
- Lead Sponsor
- Molecular Targeting Technologies, Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT00614354
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University Hospital Case Medical Center, Cleveland, Ohio, United States
🇺🇸Yale University, New Haven, Connecticut, United States
© Copyright 2025. All Rights Reserved by MedPath